Real‐time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridization probes technologiesJoaquín Martínez‐López, Florinda Gilsanz, Almudena Crooke et al.|International Journal of Laboratory Hematology|2009Cited by 9
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on TreatmentNerea Vega‐García, Mireia Camós, Margarita Ortega et al.|Frontiers in Pediatrics|2021Cited by 9
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA GroupTamara Castaño-Bonilla, Pau Montesinos, Eva Barragán et al.|Disease Markers|2022Cited by 2